Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT01506700Terminated

Real Time Optical Coherence Tomography (OCT) of Human Tissue

Role: lead

NCT02313116Suspended

Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part B)

Role: lead

NCT01699867Completed

Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part A)

Role: lead

All 3 trials loaded